(Q54976653)

English

Targeted therapy for premenopausal women with HR+, HER2- advanced breast cancer: focus on special considerations and latest advances.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

title

Targeted therapy for premenopausal women with HR+, HER2- advanced breast cancer: focus on special considerations and latest advances. (English)

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

author name string

Aditya Bardia

series ordinal

1

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

Sara Hurvitz

series ordinal

2

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

language of work or name

English

0 references

publication date

8 June 2018

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

Identifiers

DOI

10.1158/1078-0432.CCR-18-0162

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

PubMed ID

29884743

1 reference

stated in

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/MED/29884743

(Q54976653)

Targeted therapy for premenopausal women with HR+, HER2- advanced breast cancer: focus on special considerations and latest advances.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)